Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10744681rdf:typepubmed:Citationlld:pubmed
pubmed-article:10744681lifeskim:mentionsumls-concept:C0014442lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C0005220lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1708096lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1709694lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:10744681lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:10744681pubmed:issue14lld:pubmed
pubmed-article:10744681pubmed:dateCreated2000-5-8lld:pubmed
pubmed-article:10744681pubmed:abstractTextLysosomal beta-D-galactosidase (beta-gal), the enzyme deficient in the autosomal recessive disorders G(M1) gangliosidosis and Morquio B, is synthesized as an 85-kDa precursor that is C-terminally processed into a 64-66-kDa mature form. The released approximately 20-kDa proteolytic fragment was thought to be degraded. We now present evidence that it remains associated to the 64-kDa chain after partial proteolysis of the precursor. This polypeptide was found to copurify with beta-gal and protective protein/cathepsin A from mouse liver and Madin-Darby bovine kidney cells and was immunoprecipitated from human fibroblasts but not from fibroblasts of a G(M1) gangliosidosis and a galactosialidosis patient. Uptake of wild-type protective protein/cathepsin A by galactosialidosis fibroblasts resulted in a significant increase of mature and active beta-gal and its C-terminal fragment. Expression in COS-1 cells of mutant cDNAs encoding either the N-terminal or the C-terminal domain of beta-gal resulted in the synthesis of correctly sized polypeptides without catalytic activity. Only when co-expressed, the two subunits associate and become catalytically active. Our results suggest that the C terminus of beta-gal is an essential domain of the catalytically active enzyme and provide evidence that lysosomal beta-galactosidase is a two-subunit molecule. These data may give new significance to mutations in G(M1) gangliosidosis patients found in the C-terminal part of the molecule.lld:pubmed
pubmed-article:10744681pubmed:languageenglld:pubmed
pubmed-article:10744681pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10744681pubmed:citationSubsetIMlld:pubmed
pubmed-article:10744681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10744681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10744681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10744681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10744681pubmed:statusMEDLINElld:pubmed
pubmed-article:10744681pubmed:monthAprlld:pubmed
pubmed-article:10744681pubmed:issn0021-9258lld:pubmed
pubmed-article:10744681pubmed:authorpubmed-author:d'AzzoAAlld:pubmed
pubmed-article:10744681pubmed:authorpubmed-author:BontenEElld:pubmed
pubmed-article:10744681pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:10744681pubmed:issnTypePrintlld:pubmed
pubmed-article:10744681pubmed:day7lld:pubmed
pubmed-article:10744681pubmed:volume275lld:pubmed
pubmed-article:10744681pubmed:ownerNLMlld:pubmed
pubmed-article:10744681pubmed:authorsCompleteYlld:pubmed
pubmed-article:10744681pubmed:pagination10035-40lld:pubmed
pubmed-article:10744681pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:meshHeadingpubmed-meshheading:10744681...lld:pubmed
pubmed-article:10744681pubmed:year2000lld:pubmed
pubmed-article:10744681pubmed:articleTitleProcessing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.lld:pubmed
pubmed-article:10744681pubmed:affiliationDepartment of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.lld:pubmed
pubmed-article:10744681pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10744681pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10744681lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10744681lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10744681lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10744681lld:pubmed